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Abstract
We have developed an in vitro muscle preparation suitable for
metabolic studies with human muscle tissue and have investi-
gated the effects of obesity and non-insulin-dependent diabetes
mellitus (NIDDM) on glucose transport. Transport of 3-0-
methylglucose and 2-deoxyglucose was stimulated approxi-
mately twofold by insulin in muscle from normal nonobese
subjects and stimulation occurred in the normal physiological
range of insulin concentrations. In contrast to insulin stimula-
tion of 3-0-methylglucose and 2-deoxyglucose transport in
muscle from normal, nonobese subjects, tissue from morbidly
obese subjects, with or without NIDDM, were not responsive
to insulin. Maximal 3-0-methylglucose transport was lower in
muscle of obese than nonobese subjects.
Morbidly obese patients, with or without NIDDM, have a
severe state of insulin resistance in glucose transport. The
novel in vitro human skeletal muscle preparation herein de-
scribed should be useful in investigating the mechanism of this
insulin resistance.
Introduction
The cardinal manifestation of diabetes is hyperglycemia,
which in the patient with non-insulin-dependent diabetes
mellitus (NIDDM),' is most likely due to tissue resistance to
insulin action and relative insulin deficiency. In the postpran-
dial state the hyperglycemia seems to be primarily caused by
insulin resistance of glucose transport and utilization in the
peripheral tissues, whereas in the fasting condition overpro-
duction ofglucose by the liver appears to be the primary cause
of hyperglycemia (1-4). Approximately 85% of a glucose load
is taken up by skeletal muscle in a normal individual and in
NIDDM insulin resistance in muscle makes a very large con-
tribution to the observed postprandial hyperglycemia (2).
In vivo techniques, such as the euglycemic clamp, have
been extremely important in defining the changes that occur in
diabetes. However, ifthe mechanisms underlying insulin resis-
tance are to be understood, one must be able to study the
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insulin resistance in in vitro preparations of skeletal muscle.
We have developed such a preparation using muscle samples
from morbidly obese and nonobese patients undergoing ab-
dominal surgery. Thin muscle strips are mounted in clamps at
resting length and incubated in vitro in a manner analogous to
the stripped soleus muscle preparations from rats. This human
muscle preparation is metabolically viable and structurally in-
tact, and is responsive to insulin. We herein report the proce-
dures for preparation and incubation of this muscle prepara-
tion, the data demonstrating its viability, and measurements of
3-0-methylglucose and 2-deoxyglucose transport in muscle of
nonobese subjects and morbidly obese subjects with and with-
out NIDDM.
Methods
Materials. [Methyl-3H]3-O-methyl-D-glucose (20-60 Ci/mmol) and
[U-'4C]sorbitol (150-250 mCi/mmol) were obtained from ICN Radio-
chemicals, Irvine, CA. 2-[1,2-3H(N)J-Deoxy-D-glucose (30.2 Ci/mmol)
was obtained from New England Nuclear, Boston, MA. Unless other-
wise stated, all other chemicals were obtained from Sigma Chemical
Co., St. Louis, MO.
Human subjects. 9 nonobese patients, 11 morbidly obese patients
with normal glucose tolerance, and 10 morbidly obese patients with
NIDDM served as subjects. One nonobese patient was a kidney donor
while the remainder had elective hysterectomies. Two ofthe morbidly
obese patients had hysterectomy surgery while the remainder had gas-
tric bypass surgery for the treatment of their obesity. The physical
characteristics of the subject groups are shown in Table I.
None ofthe subjects had any diseases or had taken any medications
known to alter carbohydrate metabolism for at least 3 wk before sur-
gery. The experimental protocol was explained to all subjects and
informed consent was obtained. The project was approved by the East
Carolina University Policy and Review Committee on Human Re-
search. All subjects had maintained constant body weight during the
months preceding admission. Records of food intake of the morbidly
obese patients demonstrate that 15% of the calories were derived
from proteins, 39% from fat, and 49% from carbohydrates, which is the
typical distribution of calories for this population of patients in North
Carolina (5). Because ofthe effect that the caloric intake and its distri-
bution might have on this study, the morbidly obese subjects were
admitted into the hospital 4 d before surgery. During this period, they
remained active at approximately their prehospital exercise level. They
received a weight-maintaining diet providing 50% of the calories as
carbohydrates, 30o as fat (polyunsaturated/saturated fat ratio of 0.4
and cholesterol content of 600 mg), and 20% protein. Every morbidly
obese patient without known diabetes mellitus had a 75-g oral glucose
tolerance test as an outpatient. Their carbohydrate intake was > 150 g
daily for the preceding 3 d before the test. The criteria of the National
Diabetes Data Group (6) were used to classify these patients as nondia-
betics. Oral glucose tolerance tests were not performed in the morbidly
obese patients who had previously been diagnosed as having diabetes.
The subjects underwent surgery after an overnight fast. General
anesthesia was induced with a short-acting barbituate, and maintained
by phentanyl and nitrous oxide-oxygen mixture. Only saline was given
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Table L Clinical and Biochemical Data of Nonobese, Obese-Nondiabetic, and Obese-NIDDM Subjects
Age Body weight Body mass index Fasting glucose Fasting insulin
yr kg kg/r mg/dl ttU/ml
Nonobese (8 females) 37±2 60±3 22±1 95±5 Not determined
Obese-nondiabetic (11 females) 35±2 127±9* 47±3* 102±4 42±8
Obese-NIDDM (7 females) 36±3 119±4* 46±2* 135±9*0 46±5
Obese-NIDDM (3 males) 27±5 182±29** 55±9* 204±27*t§ 75±2
Values are mean±SEM. * Significantly different (P < 0.05) than the nonobese group. * Significant difference (P < 0.05) between obese-
NIDDM (female) and obese-NIDDM (male) groups. 0 Significant difference (P < 0.05) between obese-nondiabetic and obese-NIDDM.
intravenously before the biopsy. After opening the abdomen, a biopsy
3 X 2 X 2 cm from the rectus abdominus muscle was excised from the
incision area.
Human muscle strip preparation. A human muscle preparation was
modelled after the stripped rat soleus muscle preparations in rats (7).
To mount muscle at in vivo length, we constructed two sets of clamps:
one was 3 cm wide (constructed from two pairs of hemostats) and the
second was 1.5 cm wide (constructed from two pieces ofplexiglass with
a fulcrum). The surgeon places a 3-cm clamp on the muscle before it is
excised. After excision the muscle sample and the 3-cm clamp are
placed in oxygenated Krebs-Henseleit buffer for rapid transport back
to the laboratory (- 5 min). In the laboratory, muscle fiber strips
weighing 50-80 mg are "teased" from the mounted muscle sample and
a smaller clamp is placed on the muscle strip before it is cut free. The
muscle fiber strips are 12-14 mm long, 3-5 mm wide, and 0.5-1.0 mm
thick. From a muscle sample that is 3 X 2 X 2 cm we can prepare 8-12
muscle strips in 10-15 min. Pictures of a muscle sample in the 3-cm
clamp and a muscle strip in the 1.5-cm clamp are shown in Fig. 1.
After preparation, the muscle strip and clamp are placed in a spe-
cially constructed chamber containing 3.0 ml of Krebs-Henseleit
buffer with 1% bovine serum albumin (fatty acid poor, dialyzed against
Krebs-Henseleit buffer), and either 5 mM glucose or 1 mM pyruvate.
The chamber was constructed of plexiglass to consist of 12 chambers
(each 3 cm long, 1.5 cm wide, and 3 cm deep) with a lid fitted with
tubing so that each chamber could be gassed with 02/CO2 (95%:5%).
The chamber was fitted in a shaking water bath at 37° C.
Ultrastructural analysis. Tissue for electron microscopy was fixed
in one-half strength Karnovsky's fixative, postfixed in osmium tetrox-
ide, sectioned at 60-90 nm, and stained with uranyl acetate and lead
citrate. Ultrathin sections were examined on a Zeiss EM 109 (Carl
Zeiss, Inc., Thornwood, NY).
Metabolite analysis. To demonstrate the metabolic viability ofthis
muscle preparation, muscle strips were prepared and incubated for 40
min with 1 mM pyruvate as substrate as described above and then the
muscle strips were frozen in liquid nitrogen. For comparison a small
portion of the muscle sample was also quickly frozen between alumi-
num clamps cooled in liquid nitrogen immediately after it was re-
moved (sample designated fresh). The frozen muscle samples were
weighed and homogenized for lO s in a Polytron homogenizer in 9 vol
of ice-cold 7% perchloric acid. The homogenates were centrifuged and
the supernates were neutralized with 2 N K2CO3 containing 100 mM
triethanolamine. The precipitated KCl04 was separated by centrifuga-
tion and the supernate solutions were assayed for ATP, ADP, and
AMP and creatine phosphate by fluorimetric enzymatic assays (8).
3-0-Methylglucose and 2-deoxyglucose transport. The procedure
for 3-O-methylglucose uptake in muscle fiber strips was an adaptation
of the method described by Wallberg-Henriksson and Holloszy (9) for
rat muscle incubations. The human muscle fiber strips, mounted in
1.5-cm clamps, were incubated in 3.0 ml of medium consisting of
Krebs-Henseleit buffer, 1% bovine serum albumin, 1.0 mM pyruvate,
and porcine insulin (0- 10-' M). The mixture was gassed with 02/C02
(95%:5%) and the muscles were allowed to preincubate for 30 min.
After the preincubation 30 ,l of the following solution was added: 2.0
M sorbitol, 0.5 M 3-O-methylglucose containing 10 ACi/ml [14C]-
sorbitol and 20 MCi/ml [3H]3-O-methylglucose. Final concentrations
were 5.0 mM 3-O-methylglucose and 20 mM sorbitol. The mixture
was then gassed again and incubated for precisely 10 min. The muscles
were quickly removed from the medium onto a blotter, rinsed in a
stream of Krebs-Henseleit buffer, and again blotted to remove excess
moisture. The muscle strips were weighed within 5 min and oxidized in
a Packard 306 sample oxidizer (Packard Instrument Co., Inc.,
Downers Grove, IL) to determine 14C and 3H radioactivity. Accumu-
lation of [3H]3-O-methylglucose was corrected for the ['4C]sorbitol
space.
2-Deoxyglucose uptake was assayed as described for 3-0-methyl-
glucose except that [3H]2-deoxyglucose (0.04 ,Ci/Mmol) replaced 3-0-
methylglucose and the reaction was extended to 60 min. After the
incubation period, the muscle fiber strips and clamps were blotted
lightly and transferred to a chamber containing 4.0 ml of ice-cold
Krebs-Henseleit buffer. After a 5-min postincubation the buffer was
changed and the muscle fiber strips were again postincubated for 5 min
to remove extracellular [3H]2-deoxyglucose. The muscle was then re-
moved, blotted, trimmed from the clip, weighed, lyophilized, weighed
again, solubilized, and counted by liquid scintillation for 3H and 14C
radioactivity. The small amount of extracellular 2-deoxyglucose re-
maining was corrected from the sorbitol remaining in the sample.
Results
To establish that our muscle preparation was appropriate for
the metabolic studies that we planned to conduct, it was neces-
sary to demonstrate that the in vitro incubated muscle fiber
strips were viable. To show that the muscle preparation was
structurally intact and had normal membrane structure, we
performed electron-microscopic examination of fresh and in-
cubated muscle. The most sensitive indicators of metabolic
viability are the energy charge of the muscle and the ability to
respond to hormones. Therefore we measured the concentra-
tions of the energy-linked metabolites in fresh and incubated
muscle and determined the degree of insulin stimulation of
glucose transport in incubated muscle fiber strips.
Ultrastructure ofincubated musclefiber strips. To establish
that in vitro incubation ofthe muscle fiber strips does not alter
the structure of the muscle, electron-microscopic examination
of fresh and incubated muscles from obese and nonobese sub-
jects was performed. There was little difference between fresh
and incubated muscle ultrastructure. The cells were intact,
nuclei showed normal chromatin patterns, the sarcomeres
were intact, and there was no appreciable mitochondrial
swelling. In Fig. 2 the intact cell membrane of an incubated
muscle fiber strip is evident as is the normal architecture ofthe
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Figure 1. Preparation and incubation of muscle fiber strips. (A) The
surgeon places a 3-cm clamp on the muscle before it is excised and
then muscle strips weighing 50-100 mg are "teased" loose from the
rest of the muscle sample. (B) A 1.5-cm clamp is placed on the mus-
cle fiber strip before it is cut free. (C) The clamp and muscle fiber
strip are incubated in 3.0 ml of medium.
muscle. The z-lines are in register and the thick and thin fila-
ments can be seen. The nuclei are well preserved and the mi-
tochondria are intact with distinct cristae.
One of the initial concerns about the muscle fiber strip
preparation was whether the sarcolemmal membranes would
be sufficiently intact so that transport studies could be per-
formed. To test whether the muscle fiber strips were "leaky,"V
we measured the sorbitol space after various lengths of incu-
bation. The sorbitol space after 20 min of incubation (Fig. 3)
was very similar to that measured at 10 min in another set of
incubations (see Fig. 5) and it did not significantly change after
60 mmn of incubation. We take this as evidence for the intact-
ness of the muscle fibers and for the fact that the cut fiber ends
are effectively sealed by the clamp. If there had been significant
nonspecific diffusion of material into the muscle fiber strip we
would have observed a continual increase in the sorbitol space.
Metabolite concentrations in fresh and incubated muscle.
The concentrations of ATP, ADP, AMP, and creatine phos-
phate in fresh (frozen immediately after excision) and incu-
bated muscle fiber strips are shown in Fig. 4. The concentra-
tion of ATP was significantly reduced in incubated muscle
fiber strips compared to fresh muscle. However, this change is
most likely due to a decrease in the total adenine nucleotide
pool (10) since the concentrations of creatine phosphate and
AMP were not changed and the ATP:(ADP + AMP) ratio was
not different in fresh and incubated muscle. In one set of
incubated muscle fiber strips we measured the glycogen con-
tent before and after incubation. The data (Fig. 4) suggest that
there is little net glycogenolysis during the incubation.
3-0-Methylgiucose and 2-deoxyglucose transport in incu-
bated muscle fiber strips. Basal 3-O-methylglucose uptake (in
the absence of insulin) was -8 nmol/min . g for four of the
five nonobese subjects studied (Fig. 5). The fifth subject, how-
ever, had a basal uptake rate of -35 nmol/min . g and we
designated this subject a "hyperresponder" because of the ob-
vious difference from the other subjects. We examined several
clinical parameters of this hyperresponder but found no un-
usual information that would explain the difference. All five
nonobese subjects demonstrated an increase in 3-0-methyl-
glucose transport in response to 10-7 M insulin. The average
fold stimulation was 2.5 with a range of 1.8-3.0.
One of the difficulties with studying glucose transport with
3-0-methylglucose was that the extracellular 3-0-methylglu-
cose was a high proportion of the total tissue 'H radioactivity
(intracellular 3H was 10.1± 1.4% of the total tissue 3H radioac-
tivity in the basal incubations). This presented a large "blank"
value that had to be corrected by the sorbitol space. To lower
the extracellular background we decided to use 2-deoxyglucose
as a glucose analogue and then rinse out the extracellular 2-de-
oxyglucose in a postincubation at ice-cold temperatures. This
is possible because 2-deoxyglucose is phosphorylated intracel-
lularly by hexokinase and the phosphorylated derivative can-
not exit the cell. The cold temperature postincubation was
used so that extracellular 2-deoxyglucose could diffuse out but
carrier mediated uptake would be very low. Using this method
the intracellular (3H]deoxyglucose was 33±4% of the total 3H
radioactivity in the tissue incubated in the absence of insulin.
There are two requirements for the use of 2-deoxyglucose
for transport studies. First, it must be shown that the rate of
transport is linear over the incubation period so that ATP is
not being depleted as phosphate is incorporated irreversibly
into 2-deoxyglucose. Secondly, it must be demonstrated that
phosphorylation of 2-deoxyglucose is not limiting the rate of
uptake. We have measured 2-deoxyglucose uptake into muscle
fiber strips at 50 mM 2-deoxyglucose in the presence of 10-7 M
insulin. These conditions were chosen because this should
produce the highest transport rate, and thus be the most strin-
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Figure 2. Electron micrograph of an incubated muscle fiber strip.
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Figure 3. Sorbitol space in muscle fiber strips after varying lengths of
incubation. Values are mean±SEM for six observations (four non-
obese and two obese subjects).
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FigureS. 3-0-Methylglucose
transport in muscle fiber strips
of nonobese subjects in the ab-
sence (-I) or presence (+I) of
lO-' M insulin. There was one
nonobese sample that had very
,7 high 3-0-methylglucose uptake
z- compared to the others and
was thus not included in the
data shown above. The values
for this hyperresponder in the
absence and presence of 10-'
M insulin were 35.2 and 86.4
+1 nmol/min * g.
gent test for the requirements of the system. The rate of 2-de-
oxyglucose uptake was linear for at least 60 min (Fig. 6) and
most of the intracellular 2-deoxyglucose was phosphorylated
(84.7±0.3% phosphorylated in the presence of 10-' M insulin
and 89.5±4.1% phosphorylated without insulin; n = 3). The
intracellular concentration of nonphosphorylated 2-deoxyglu-
cose in these incubations was - 1.6 mM. These data demon-
strate that our assay of2-deoxyglucose uptake is appropriate to
study glucose transport.
2-Deoxyglucose transport into muscle fiber strips was
measured in the absence of insulin and at three insulin con-
centrations to establish an insulin dose-response curve (Fig. 7).
Consistent with the 3-O-methylglucose transport data, insulin
stimulated 2-deoxyglucose transport approximately twofold
and stimulation was in the physiological range of plasma insu-
lin concentrations.
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Figure 4. Metabolite levels in control (quickly frozen) and incubated
(40 min) muscle samples. Adenine nucleotides were assayed in seven
subjects (three obese and four nonobese) while creatine phosphate
was assayed in five samples (three obese and two nonobese). The gly-
cogen concentration was determined in one obese subject. *Signifi-
cant difference (P < 0.05) between control and incubated.
Glucose transport in musclefiber stripsfrom obese subjects
with and without NIDDM. We developed the muscle fiber strip
preparation to investigate insulin action in muscle from
human subjects with insulin resistance. Obesity and NIDDM
are conditions that lead to insulin resistance (1 1-14) and there-
fore we have investigated insulin stimulation of glucose trans-
port in muscle fiber strips from morbidly obese subjects with
and without NIDDM.
Representative glucose tolerance curves for the female
subjects in the three groups are shown in Fig. 8. The obese
subjects with normal glucose tolerance demonstrate insulin
resistance because the glucose is held in the normal range by
elevated insulin levels. The diabetic subjects have a higher
degree of resistance to insulin because glucose levels are ele-
vated above normal in the face of even higher insulin levels. It
should be pointed out that the data shown in Fig. 8 for diabetic
patients do not include those patients who had been previously
diagnosed with diabetes because those patients were not given
a glucose tolerance test. The degree of severity of diabetes,
therefore, may be greater in the entire diabetic group than that
represented by the patients shown in Fig. 8.
Since the composition of muscle could be altered by obe-
sity we investigated the protein, lipid, and water content of
muscle samples for our nonobese and obese subjects (Fig. 9).
There was a significantly lower sorbitol space in obese muscle
but there were no differences in protein, lipid, or total tissue
water in incubated muscle fiber strips. We were somewhat
surprised that lipid content was not altered in obese samples
but our measurement of lipid is consistent with the electron-
microscopic examination because there were no discernable
lipid droplets. Apparently the lipid is stored primarily in adi-
pose tissue rather than being infiltrated into other tissues.
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Figure 6. Time course
for 2-deoxyglucose up-
take into incubated
muscle fiber strips.
Values are mean±SEM
for seven observations
(four nonobese and
three obese subjects).
Uptake was measured
at 50 mM 2-deoxyglu-
cose in the presence of
lO-7 insulin.
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Figure 7. Insulin stimu-
lation of 2-deoxyglucose
transport into incubated
muscle fiber strips. 2-
Deoxyglucose uptake
was measured in muscle
from four nonobese
subjects. Three samples
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Insulin Concentration (M) ure. The values for the
samples that did not
stimulate were as follows: 97, 117, 96, and 93 nmol/min - g for 0,
10-10, 10-9, and 10-7 M insulin, respectively. One of the muscle sam-
ples that did show insulin stimulation was taken from the lumbar re-
gion of the back in a kidney donation surgery. Since this is a differ-
ent muscle than the others reported, the individual values are given:
82, 163, 260, and 195 nmol/min * g for 0, 10-9, 10-8, and l0-7 M in-
sulin, respectively.
The ability of incubated muscle fiber strips to maintain
energy linked metabolite levels was investigated in samples
from obese and nonobese subjects to ascertain that both would
remain metabolically viable (Table II). There were no signifi-
cant differences in the concentrations of ATP, ADP, or AMP
between obese and nonobese in the control (quickly frozen)
muscle samples, and both groups maintained metabolic en-
ergy levels during the incubations.
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Figure 9. Content of protein, lipid, total tissue water, and extracellu-
lar water (sorbitol space) in incubated muscle fiber strips from obese
and nonobese subjects. Total tissue water was assayed gravimetrically
by difference in weight before and after lyophilization. Sorbitol space
was determined from the ['4Clsorbitol in the incubated tissue as de-
scribed in Methods. Protein was measured on a tissue homogenate
by the Lowry procedure (27). Lipid content was assayed colorimet-
rically after extraction by a modified Folch procedure (28).
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Figure 8. Plasma glucose and insulin concentrations during an oral
glucose tolerance test (GTT). (.) Samples were taken from four non-
obese female subjects who did not have surgery. (o) Values from six
female morbidly obese patients who subsequently underwent gastric
bypass surgery. (A) The obese NIDDM subjects (five females) were
unaware of their diabetic condition when they were examined for
gastric bypass surgery.
Uptake of 3-0-methylglucose by muscle strips of nondia-
betic-obese subjects demonstrated a much greater heterogene-
ity in both the basal and insulin-stimulated rates (Fig. 10) as
well as in the degree of stimulation. As in the nonobese group,
there was one muscle sample that had inordinately high rates
of 3-0-methylglucose transport (hyperresponder) and the data
of that subject is shown in the legend to Fig. 10 but was not
included with that of the other six subjects. Muscle strips from
four of the seven obese subjects with normal glucose tolerance
showed stimulation of 3-0-methylglucose transport in the
presence of 10-' M insulin while the other three were unre-
sponsive. This heterogeneity of insulin responsiveness may be
Table I. Adenine Nucleotide Levels in Control (Quickly Frozen)
and Incubated Muscle Stripsfrom Nonobese qnd Obese Subjects
ATP ADP AMP ATP/(ADP + AMP)
Nonobese (n = 4)
Control 5.2±0.3 1.4±0.2 0.35±0.02 3.0±0.2
Incubated 4.1±0.3 1.1±0.1 0.35±0.05 2.9±0.2
Obese (n = 3)
Control 6.2±0.6 1.6±0.4 0.27±0.02 3.4±0.3
Incubated 5.0±0.4 1.1±0.1 0.33±0.09 3.6±0.6
Values are mean±SEM.
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transport in muscle fiber strips
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related to the heterogeneous responses that Olefsky et al. (1)
and Kolterman et al. (1 1) observed in in vivo insulin action
and glucose transport into adipocytes of obese subjects.
The data for 3-0-methylglucose and 2-deoxyglucose trans-
port are summarized in Fig. 11 and Table III. In muscle from
nonobese subjects transport of both glucose analogues was
stimulated approximately twofold by insulin. The rates of
transport of 3-0-methylglucose and 2-deoxyglucose appear to
be dramatically different in Fig. 11 and Table III. The reason
for this difference is that uptake of 3-0-methylglucose was
expressed per gram of wet tissue and 2-deoxyglucose was ex-
pressed on a dry tissue weight basis. Since there was no differ-
ence in tissue water between obese and nonobese muscle, ei-
ther basis ofexpression should provide a valid comparison. We
measured 2-deoxyglucose uptake in muscle strips from non-
obese subjects at 5 mM concentration so that a comparison
with the rate of 3-0-methylglucose transport could be made.
The rates in the absence and presence of 10-' M insulin were
26 and 58 nmol/min g dry tissue (Table III). Since muscle
contains 75% water this would be - 6.5 and 14.5 nmol/
min * g wet tissue, which would compare well with the values
of 8±1, and 20±2 nmol/min * g wet tissue for 3-O-methylglu-
cose transport in the absence and presence of 10-0 M insulin.
By contrast with muscle samples from the nonobese group,
there was no statistically significant stimulation of glucose
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Figure 11. 3-O-Methylglucose transport in muscle fiber strips from
nonobese subjects, morbidly obese subjects with normal glucose tol-
erance, and morbidly obese subjects with NIDDM. *Significantly dif-
ferent (P < 0.05) from nonobese group (+ insulin). 'Values were
taken from Figs. 5 and 10.
Table III. Insulin Stimulation of2-Deoxyglucose Transport
into Muscle Fiber Stripsfrom Nonobese Subjects,
Nondiabetic Morbidly Obese Subjects,
and Morbidly Obese Subjects with NIDDM
2-Deoxyglucose transport
Insulin concentration 0 1 X 10-9 Maximal*
nmol/min g dry muscle
50 mM 2-deoxyglucose
Nonobese (4) 100±25 167±24 199±41
Obese-nondiabetic (4) 158±40 171±33 158±44
Obese-NIDDM (6) 133±30 152±35 132±31
5 mM 2-deoxyglucose
Nonobese (4) 26±3 58±10
Obese-nondiabetic (2) 15 (12, 18) 20 (18, 23)
Obese-NIDDM (2) 24 (27, 22) 21 (19, 24)
Values are mean±SEM. The number of observations is shown in pa-
rentheses adjacent to the group. In those instances where there were
only two subjects, individual values are given in parentheses follow-
ing the mean.
* Insulin concentration for experiments with 50 mM 2-deoxyglucose
was 1 X lo-' M while for 5 mM 2-deoxyglucose it was 1 X 10-6 M.
transport by insulin in either the obese subjects with normal
glucose tolerance or in the patients with NIDDM. In addition,
the maximally stimulated rate of 3-0-methylglucose transport
was significantly less in the obese-nondiabetic, and the
NIDDM groups than in the muscle from nonobese subjects,
but there was no difference in transport rates between the
obese-nondiabetic and the obese-NIDDM (Fig. 11). These
same trends were evident for 2-deoxyglucose transport (Ta-
ble III).
Discussion
The many published studies that have utilized isolated hepa-
tocytes and adipocytes demonstrate the importance of in vitro
studies in metabolic research. Since muscle is an important
target of insulin action, we felt that it was important that an in
vitro muscle preparation be developed that could be used on
human tissue. The rat muscle preparation that seemed to hold
the most promise for adaptation to human tissue was the
stripped soleus muscle preparation (7). For this preparation
muscle fiber bundles that run the whole length of the muscle
are separated and then the tendons are attached to a clip to
hold the muscle strip at resting length. By this procedure a
muscle that is too large to be incubated intact is reduced to a
size that allows free diffusion. In addition, attaching the mus-
cle strip to a clip has the advantage of preventing the usual
contraction of the muscle in the incubation medium which
further makes diffusion into the interior of the muscle more
difficult.
In deciding which muscle to use for a human muscle fiber
strip preparation, the rectus abdominus muscle seemed to be a
good choice because it was accessible from the incision ofmost
abdominal surgery procedures and longitudinal sections of
muscle fibers could be found along a midline incision. In the
first human muscle sample we found that we could easily tease
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out muscle strips that ran the whole length of the sample and
these strips appeared to be continuous intact fibers. When the
muscle strips were incubated in Krebs-Henseleit medium, they
contracted to a much shortened length and thus we thought
that it would be necessary to mount them at resting length
during incubation. To do this we constructed the two sets of
clamps described in Methods and the muscle was incubated
with a clamp on each end of the muscle fiber strip. Besides
maintaining the muscle strip at in vivo length, this procedure
has the added presumed advantage of sealing the cut ends of
the fibers so that intracellular contents do not leak out or
extracellular material diffuse into the open ends of the fibers.
One of our initial objectives was to show that the human
fiber strip preparations were metabolically viable. We felt that
the size of the muscle fiber strip was probably a critical param-
eter in maintaining a viable preparation so ATP concentra-
tions of muscle fiber strips of different sizes were determined
after incubation. The optimal weight of the muscle strips ap-
peared to be between 50 and 100 mg. Larger strips probably
have impaired oxygen and/or nutrient diffusion while smaller
strips are not as viable because the number of damaged fibers
on the surface of the preparation becomes a larger proportion
of the total.
Although it was important to show that our muscle fiber
strip preparation was metabolically viable and structurally in-
tact, the most important requirement of the system for the
studies that we planned was responsiveness to insulin. To es-
tablish that insulin does stimulate glucose transport in this
preparation we measured 3-O-methylglucose and 2-deoxyglu-
cose uptake under basal and insulin-stimulated conditions.
The results shown for normal weight subjects clearly demon-
strates the suitability of this preparation for these studies since
glucose transport was accelerated by insulin in eight ofthe nine
nonobese subjects. Although we cannot rule out insulin acting
through IGF-I receptors at maximal insulin concentrations,
the stimulation of glucose transport at normal physiological
insulin concentrations suggest that the response is mediated
through the insulin receptor.
The rates of 3-O-methylglucose transport in human muscle
(8.1±0.6 and 19.6±1.8 nmol/min . g for basal and insulin-
stimulated, respectively) are considerably lower than we ob-
served in rat soleus muscle (24±7 and 100±7 nmol/min * g for
basal and insulin-stimulated, respectively) but the extent of
insulin stimulation is comparable in rat and human muscle.
The rate of transport that we measure in our in vitro muscle
fiber strips may well be within the normal range of in vivo
transport of glucose since Yki-Jarvinen et al. (15) measured
glucose disposal in muscle of the forearm to be in the range of
5-250 nmol/min * g muscle (see Fig. 5 of reference 15) and the
rate of glucose disposal is likely limited by the rate of glucose
transport.
The major purpose in developing this in vitro human
muscle fiber strip preparation was to provide a system to in-
vestigate the mechanisms responsible for insulin resistance in
muscle. The results obtained on muscle from obese and dia-
betic subjects demonstrate the importance of the preparation.
Tissue from morbidly obese subjects with or without NIDDM
were not responsive to insulin. In addition, maximally insulin
stimulated 3-O-methylglucose transport was significantly
lower in normal-obese and diabetic-obese muscle samples
compared to those from nonobese subjects, but there was no
difference in transport rates between the two obese groups.
These results suggest that morbid obesity causes a severe insu-
lin resistance in muscle tissue but the defect in insulin action is
the same in subjects with or without NIDDM.
The finding that basal glucose transport does not change in
an insulin-resistant state seems in agreement with the in vivo
data of Baron et al. (16). They found that non-insulin-me-
diated glucose uptake was elevated in type II diabetic subjects
but this was a result ofthe hyperglycemia and when the plasma
glucose concentration was matched in control subjects the
basal rate of glucose utilization was the same in control and
diabetic subjects.
Sinha et al. (17, 18) measured glucose transport into adi-
pocytes and Caro et al. (19) measured amino acid transport in
hepatocytes isolated from the same groups of subjects as those
in the present study. In contrast to the results in muscle, insu-
lin responsiveness was depressed somewhat in the nondia-
betic-obese group but glucose transport rate and insulin re-
sponsiveness were depressed even further in the morbidly
obese patients with NIDDM. These results from muscle, adi-
pose tissue, and liver from the same groups ofsubjects demon-
strate that not all tissues are altered to the same extent in these
insulin-resistant states and it is not possible to investigate one
tissue or cell type and extrapolate to the response of other
tissues. Likewise a given tissue may respond differently to each
specific insulin action. For example, it is well accepted that
adipose tissue in NIDDM is resistant to insulin with respect to
glucose transport but inhibition of lipolysis is normal (20).
Also, in a lesser degree of obesity, insulin sensitivity was de-
creased but responsiveness was normal with regards to glyco-
gen synthase activation in skeletal muscle (21).
We have been especially interested in the molecular mech-
anisms that cause insulin resistance in skeletal muscle from
these patients (22). Insulin binding by solubilized insulin re-
ceptors was equally decreased in skeletal muscle from obese
patients with or without NIDDM. Likewise, insulin receptor
kinase activity was decreased in obesity without any appreci-
able additional defect when obesity was associated with
NIDDM. Thus, in skeletal muscle from individuals with se-
vere obesity, a defect in insulin-stimulated glucose transport
and insulin receptor kinase activity appears to be present. A
mechanistic relationship between these two processes is only
speculative at this time. Alternatively, a decrease in the num-
ber of intracellular glucose transporters would also explain the
insulin resistance in our patients as has been observed in adi-
pocytes from animal models of insulin resistance (21-26).
In summary, we have developed an in vitro incubated
human muscle fiber strip preparation that is structurally in-
tact, metabolically viable, and responsive to insulin. With this
preparation we have shown that maximal glucose transport
into muscle of morbidly obese individuals is depressed and
insulin responsiveness is decreased. We believe this in vitro
muscle preparation will prove to be invaluable in clinical in-
vestigations of metabolic disturbances such as obesity and
NIDDM.
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